Q: Compass Pathways looks to be in an interesting new market for magic mushroom drugs. What do you think of the shares as an investment? Thank you.

A: Compass Pathways plc (ADR), $36.19, symbol CMPS on Nasdaq (Shares outstanding: 36.7 million; Market cap: $1.4 billion; www.compasspathways.com), was founded in 2015. The company is now testing the psychoactive compound psilocybin, sometimes referred to as “magic mushrooms,” as a therapy for treatment-resistant depression, or… Read More

We don’t recommend this Goldman Sachs ETF

We don’t recommend this Goldman Sachs ETF

A Member of Pat McKeough’s Inner Circle recently asked for his advice on a fund that bases its decisions on regular polling of the American public’s opinions of ESG business behaviour.

Pat likes the low MER but questions the value of its way of choosing investment… Read More